Returning function to paralysed upper limbs is the primary goal of Orthocell trial
The Market Herald - 21-Jun-2021Peripheral nerve repair could benefit 3 million patients every year
Join the club for FREE to access the whole archive and other member benefits.
Founder and Managing Director of Orthocell Ltd
He has over 20 years’ experience in the medical device and cellular therapeutic fields with expertise in bridging the gap between research and clinical practice in the development of emerging medical technologies. This encompasses applying the regulatory framework to the product, rebating pathways, marketing, sales, developing key option leader relationships, strategic and financial planning.
Visit website: https://www.orthocell.com.au/board-of-directors
See also: Orthocell - Regenerative medicine company empowering the body to heal
Details last updated 21-Jun-2021
Peripheral nerve repair could benefit 3 million patients every year